DAWN - Company ID 0001845337
The table below shows Day One Biopharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $43.28M | $35.62M | $33.36M | $422.76M | $239.62M | $270.39M |
| Short-term investments | $408.30M | $417.48M | $439.66M | $135.62M | $122.25M | $47.55M |
| Receivables | - | - | - | - | - | - |
| Inventory | $7.06M | $6.54M | $3.56M | $2.73M | $151.00K | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $489.97M |
| $494.43M |
| $508.65M |
| $581.00M |
| $383.16M |
| $326.03M |
| Property, plant & equipment | $2.23M | $2.32M | $2.51M | $904.00K | $196.00K | $185.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $513.78M | $519.04M | $534.36M | $600.81M | $400.44M | $326.64M |
| Accounts payable | $5.78M | $5.09M | $2.54M | $3.02M | $6.44M | $4.78M |
| Total current liabilities | $56.47M | $51.22M | $47.88M | $39.74M | $93.71M | $29.84M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $62.91M | $58.20M | $54.84M | $45.34M | $93.71M | $29.84M |
| Retained earnings | -$640.13M | -$620.40M | -$590.08M | -$488.37M | -$525.40M | -$521.00M |
| Total equity | $450.87M | $460.83M | $479.51M | $555.46M | $306.73M | $296.81M |